Navigation Links
Curemark CEO Presents at Epigenomics Conference
Date:8/24/2009

RYE, N.Y., Aug. 24 /PRNewswire/ -- Curemark Founder and CEO Dr. Joan Fallon delivered the Industry Keynote address at the Third International Epigenomics, Sequencing 2009 Conference at Harvard Medical School on July 14th.

Dr. Fallon's selection to address this cutting-edge conclave is particularly significant, since epigenetics is the study of heritable changes in gene function that occur without a change in the DNA sequence. Presenters at the session showcased many leading researchers, representing Harvard, Columbia and Duke Universities along with MIT and many others.

Dr. Fallon's message focused on Curemark's patented new science, which distinguishes a subset of children with autism. Labeled most recently by the geneticists as "the autisms", the multiple phenotypes which fall on the autism spectrum have yet to be fully delineated on a gene level. Curemark's science provides a route to identify a specific, diagnosable subset of children with autism.

"I'm honored to have been selected, among such distinguished leaders in both academia and industry, to speak at this conference," stated Fallon. "The opportunity to discuss Curemark's science in front of this esteemed group is so important to children with autism around the world as well as

to Curemark," she continued.

Curemark is presently conducting a FDA phase III clinical trial for autism.

About CUREMARK LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases especially those with dysautonomic components by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit '/>"/>

SOURCE Curemark LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Curemark Appoints Preeminent Pediatrics Gastroenterologist
2. Curemark Closes Series A Financing
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... and SHANGHAI , Sept. ... (BHG), a global knowledge leader in healthcare technology, ... to support healthcare innovation in China ... connected health technologies. Continua and BHG announced this ... being held this week in Washington, ...
(Date:9/22/2014)... , Sept. 22, 2014 ... of the "Global Ablation Technologies (Radiofrequency, Ultrasound, ... 2019" report to their offering. ... the global ablation technologies market has been divided ... ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation technologies. ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
(Date:9/23/2014)... A 2014 study supported by the ... has found that rising temperatures and hotter ... children developing kidney stones. Researchers based their findings ... U.S. cities, including Dallas, Atlanta, Philadelphia, Chicago and Los ... for kidney stones within a relatively short span – ...
(Date:9/23/2014)... 23, 2014 ClickFunnels 2.0 ... application has created a buzz of excitement throughout the ... this new software has caught the attention of HonestyFirstReviews.com’s ... her readers. , “The technical aspects of ... and development can be quite daunting,” reports Hendricks. “In ...
(Date:9/23/2014)... from the University of Toronto, directed by Drs. ... in normal vestibular nerves and vestibular schwannomas (VSs). ... negligible difference between VSs that sporadically occur and ... a genetic disorder; and 2) the overexpressed PI3K/AKT/mTOR ... excellent therapeutic target. Detailed findings of this study ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 Rinovum ... home-use conception assistance device on the market cleared by ... in stores and online at http://www.storkotc.com . , ... dream of having a baby is delayed by infertility1 ... first step to optimize their chances to conceive. ...
(Date:9/23/2014)... 2014 Ale Gicqueau, President and Chairman ... Data Visualization for Clinical Trials at the upcoming ... Francisco on Friday, September 26, 2014. , PhUSE ... its inception, PhUSE has expanded from its roots as ... platform for the discussion of topics encompassing the work ...
Breaking Medicine News(10 mins):Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 3Health News:ClickFunnels 2.0 – Review Of Russell Brunson’s Sales Funnel Building Software Released 2Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 2Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2
... , ... Automates Consumer Tracking and Claims Workflow to Help Organizations Take Control of Medicaid Waivers ... Reston, ... in integrated health and human services management, announced today the immediate availability of ...
... ... also understands the value of providing excellent customer service to their customers. The customer ... A recent award from third party evaluators at STELLAService, ranks Anjolee high in three ... ...
... ... increase in business as the reward for providing personalized service and customized medications. The ... medicine. , ... Scottsdale, AZ (PRWEB) May 5, 2010 -- While important veterinary drugs remain in ...
... ... Yagodich – podiatrists at Your Next Step in Ardmore and Paoli, Pennsylvania – excitedly ... patients that suffer from toenail fungus. , ... Ardmore and Paoli, Pennsylvania (Vocus) May 4, 2010 -- ...
... ... and teff provide important nutrients for the gluten-free diet, but Carol Fenster bakes with sorghum ... To celebrate May as National Celiac Awareness month, she offers a free sorghum-based cookbook, Gluten-Free ... , ...
... helped some with respiratory disease, but more study ... Treatment with the antibiotic azithromycin doesn,t improve the ... fibrosis, U.S. researchers report. , "A vicious cycle ... and premature death in patients with cystic fibrosis ...
Cached Medicine News:Health News:Harmony Information Systems Announces Availability of Harmony for Aging Waivers Edition 2Health News:Harmony Information Systems Announces Availability of Harmony for Aging Waivers Edition 3Health News:Anjolee Receives Stellar Customer Service Award from STELLAService 2Health News:Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages 2Health News:Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages 3Health News:Over 450 Patients Now Toenail Fungus Free Thanks to Your Next Step's New Toenail Fungus Laser Treatment Technology 2Health News:Carol Fenster Offers Tips for Gluten-Free Cooking with Sorghum: May is National Celiac Awareness Month 2Health News:Azithromycin Doesn't Always Help Lungs in Cystic Fibrosis Patients 2
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant....
Intermittent catheter...
... assay is a rapid and accurate bedside test ... assisting the diagnosis and assessment of patients with ... speed and accuracy profit from a ... assay = 12 minutes. In emergency departments Point ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: